Hydrochloric Acid → 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-5-oxo-pentanoic acid methyl ester

HRID 858909

Reaction equation

HRID 858909 reaction equation
[CH3:1][O:2][C:3](=[O:29])[CH:4]([C:12]1[N:16]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:15]2=[N:14][C:13]=1[C:22]1[CH:27]=[CH:26][C:25]([CH3:28])=[CH:24][CH:23]=1)[CH2:5][CH2:6][CH:7]1OCC[O:8]1.Cl>CC(C)=O>[CH3:1][O:2][C:3](=[O:29])[CH:4]([C:12]1[N:16]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:15]2=[N:14][C:13]=1[C:22]1[CH:27]=[CH:26][C:25]([CH3:28])=[CH:24][CH:23]=1)[CH2:5][CH2:6][CH:7]=[O:8]

Participants

4

Procedure

To a magnetically stirred solution of (+/−)-4-[1,3]dioxolan-2-yl-2-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-butyric acid methyl ester 35b (0.10 g, 0.253 mmol) in acetone (5 mL) at room temperature under Ar atmosphere was slowly added 5N HCl (1.5 mL). The reaction mixture was stirred for 2 h and then concentrated in vacuo to remove acetone. NaHCO3 solution (100 mL) was added until the pH is greater than 9, and the aqueous phase was extracted with ethyl acetate (2×100 mL). The combined organic layers were washed with water, dried (MgSO4), and concentrated in vacuo to provide 0.064 g (75%) of the crude product. 1H NMR (400 MHz, CDCl3) δ 2.24 (m, 4H), 2.34 (s, 3H), 2.39 (s, 3H), 3.70 (s, 3H), 4.38 (t, J=8.1 Hz, 1H), 7.03 (d, J=1.4 Hz, 1H), 7.24 (d, J=7.3 Hz, 2H), 7.56 (m, 3H), 7.99 (s, 1H), 9.48 (s, 1H).

Workup

  1. customat room temperature
  2. concentrationconcentrated in vacuo
  3. customto remove acetone
  4. additionNaHCO3 solution (100 mL) was added until the pH is greater than 9
  5. extractionthe aqueous phase was extracted with ethyl acetate (2×100 mL)
  6. washThe combined organic layers were washed with water
  7. dry with materialdried (MgSO4)
  8. concentrationconcentrated in vacuo

Sources & evidence

ORD record
ord-87bc952b95994704a40d551c6da0eab6
Source dataset
uspto-grants-2006_12
Patent number
US07148353B2

Linked notes

Loading…